Alembic Limited (NSE:ALEMBICLTD)

Alembic Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	2,224	2,400	2,219	1,575	1,272	782.18
Revenue Growth	-0.64%	8.16%	40.89%	23.77%	62.68%	6.40%
Gross Profit Gross Profit Growth	1,509	1,551	1,429	1,000	809.9	496.07
Operating Income Operating Income Growth	632.02	777.12	830.79	490.22	336.09	90.67
Net Income Net Income Growth	3,550	3,174	3,107	2,686	1,906	2,221
Earnings Per Share EPS Growth	13.83	12.36	12.10	10.46	7.42	8.65
EPS Growth	9.67%	2.16%	15.66%	40.90%	-14.14%	-35.23%

Revenue by Segment

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Active Pharmaceutical Ingredient (API) Active Pharmaceutical Ingredient (API) Growth	465.85	322.15	317.42	264.88	322.66
Real Estate Real Estate Growth	1,934	1,897	1,257	1,008	459.51
Total Total Growth	2,400	2,219	1,575	1,272	782.18

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	1,221	980.38	582.7	128.57	463.55	270.43
Total Debt Total Debt Growth	-	106.39	144.47	91.49	-	-
Net Cash (Debt) Net Cash Growth	1,221	874	438.23	37.08	463.55	270.43
Net Cash Growth	66.63%	99.44%	1081.85%	-92.00%	71.41%	21.69%
Net Cash Per Share Net Cash Per Share Growth	4.76	3.40	1.71	0.14	1.81	1.05

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	1,004	1,201	863.7	226.87	388.53	-177.47
Capital Expenditures CapEx Growth	-612.71	-766.51	-507.66	-562.9	-258.18	-358.13
Free Cash Flow Free Cash Flow Growth	391.74	434.14	356.05	-336.03	130.35	-535.6
Free Cash Flow Growth	-13.46%	21.93%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	67.86%	64.62%	64.39%	63.51%	63.65%	63.42%
Operating Margin	28.42%	32.38%	37.44%	31.13%	26.41%	11.59%
Pretax Margin	168.16%	141.76%	144.94%	176.80%	154.69%	298.81%
Profit Margin	159.64%	132.25%	140.02%	170.57%	149.83%	283.90%
FCF Margin	17.62%	18.09%	16.05%	-21.34%	10.24%	-68.48%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	2.400	2.400	2.400	2.400	2.200	1.800
Dividend Per Share Growth	0%	0%	0%	9.09%	22.22%	800.00%
Dividend Yield	2.09%	3.38%	2.44%	2.87%	3.71%	2.49%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	8.31	5.74	8.14	8.00	7.99	8.37
P/FCF Ratio	69.50	41.94	71.03	-	116.80	-
PS Ratio	12.24	7.59	11.40	13.64	11.97	23.75

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error